SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-005043
Filing Date
2024-02-06
Accepted
2024-02-06 09:09:52
Documents
19
Period of Report
2024-02-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 44330
2 ex1-1.htm EX-1.1 291048
3 ex5-1.htm EX-5.1 9651
4 ex99-1.htm EX-99.1 10403
5 ex99-2.htm EX-99.2 13536
6 ex99-2_001.jpg GRAPHIC 5376
  Complete submission text file 0001493152-24-005043.txt   626243

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE immx-20240206.xsd EX-101.SCH 3015
8 XBRL LABEL FILE immx-20240206_lab.xml EX-101.LAB 34240
9 XBRL PRESENTATION FILE immx-20240206_pre.xml EX-101.PRE 22359
20 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3790
Mailing Address 10573 W. PICO BLVD. #58 LOS ANGELES CA 90064
Business Address 11400 WEST OLYMPIC BLVD. SUITE 200 LOS ANGELES CA 90064 (888) 958-1084
Immix Biopharma, Inc. (Filer) CIK: 0001873835 (see all company filings)

IRS No.: 454869378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41159 | Film No.: 24598283
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)